Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Side 1 fra 22 resultater
Combined anti-tumor therapy with interleukin-2 and histamine, analogs thereof or H.sub.2 -receptor agonists
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD
This invention relates to the field of anti-tumor therapy, and more particularly to the treatment of malignant tumors with interleukin-2 (IL-2). The improvement provided by the present method is the co-administration of the IL-2 with an agent such as histamine, histamine structural
Synergistic tumorcidal response induced by histamine
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to methods of treating cancer in which histamine is administered in conjunction with other cancer therapies. The cancer therapy includes surgery, radiation, immunotherapy, the administration of an agent which enhances the humoral immune response
Treatment method for cancer
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF INVENTION
The present invention relates to the improved treatment of cancer in animals, including humans, using chemotherapeutic agents.
BACKGROUND TO THE INVENTION
One of the major chemotherapeutic treatments is that of malignant growth (cancer) in humans. The objective of chemotherapy is
Treatment method for cancer
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF INVENTION
The present invention relates to the improved treatment of cancer in animals, including humans, using chemotherapeutic agents.
BACKGROUND TO THE INVENTION
One of the major chemotherapeutic treatments is that of malignant growth (cancer) in humans. The objective of chemotherapy is
Treatment method for cancer
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF INVENTION
The present invention relates to the improved treatment of cancer in animals, including humans, using chemotherapeutic agents.
BACKGROUND TO THE INVENTION
One of the major chemotherapeutic treatments is that of malignant growth (cancer) in humans. The objective of chemotherapy is
Treatment method for cancer
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF INVENTION
The present invention relates to the improved treatment of cancer in animals, including humans, using chemotherapeutic agents.
BACKGROUND TO THE INVENTION
One of the major chemotherapeutic treatments is that of malignant growth (cancer) in humans. The objective of chemotherapy is
Method for treatment of cancer and infectious disease
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order, for example, to treat tumors or virus infections.
SUMMARY OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously cytotoxic
Method for treatment of cancer and infectious disease
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order, for example, to treat tumors or virus infections.
SUMMARY OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously cytotoxic
Preparation for activation of natural killer cells (NK-cells), said preparation containing interferon-alpha and histamine, serotonin, amines or substances with corresponding receptor activity
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order for example, to treat tumors or virus infections.
BACKGROUND OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously
Histamine-releasing factor (HRF), HRF-receptor and methods of modulating inflammation
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Aug. 18, 2014, is named LIAI0433629_ST25.txt and is 21,069 bytes in
Substituted tricyclic heterocycles as histamine 4 receptor inhibitors
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a national phase application of PCT Application No. PCT/KR2012/007965, filed on Sep. 28, 2012, which claims the benefit and priority to Korean Patent Application No. 10-2011-0100369, filed Sep. 30, 2011 and claims the benefit and priority
Composition for treating hormonally-dependent cancers
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION
The invention is generally related to the treatment of inflammatory conditions. More specifically, the invention is related to compositions containing inhibitors of mast cell activation and secretion such as a proteoglycan that are designed to be used as dietary
Method for treatment of cancer and infectious disease
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention concerns a pharmaceutical preparation or system for activation of natural killer cells (NK-cells), in order, for example, to treat tumors or virus infections.
BACKGROUND OF THE INVENTION
Natural killer cells (NK-cells) are a group of spontaneously
Immunomodulating and antiinflammatory agent
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to the use of a histamine-added gamma-globulin as pharmaceuticals. More particularly, it relates to an immunomodulating agent, a suppressive agent to hypereosinophilicity and an antiinflammatory agent containing the histamine-added gamma-globulin
Immunomodulating and antiinflammatory agent
Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
FIELD OF THE INVENTION
The present invention relates to the use of a histamine-added gamma-globulin as pharmaceuticals. More particularly, it relates to an immunomodulating agent, a suppressive agent to hypereosinophilicity and an antiinflammatory agent containing the histamine-added gamma-globulin
Den mest komplette database med medicinske urter understøttet af videnskab
- Arbejder på 55 sprog
- Urtekurer, der understøttes af videnskab
- Urtegenkendelse ved billede
- Interaktivt GPS-kort - tag urter på stedet (kommer snart)
- Læs videnskabelige publikationer relateret til din søgning
- Søg medicinske urter efter deres virkninger
- Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter
Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning
